CompoAtlas

PharmaSelect ImmuPro Capsule

PharmaSelect ImmuPro Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL22106071TC
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
ASIA HEALTHCARE SDN. BHD.
Manufacturer
YANLING NATURAL HYGIENE SDN. BHD.
Registration period starting
2022-10-18
Published validity end
2027-10-18

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Lignosus rhinocerusLignosus rhinocerus[250.00 mg,570.00 mg]Not identified
Astragalus membranaceusAstragalus membranaceus[50.00 mg,570.00 mg]Not identified
Cordyceps sinensisCordyceps sinensis[200.00 mg,570.00 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Lignosus rhinocerus[250.00 mg,570.00 mg],Astragalus membranaceus[50.00 mg,570.00 mg],Cordyceps sinensis[200.00 mg,570.00 mg]
Valid until
2027-10-18
Registration date
2022-10-18
Published description
NATURAL PRODUCT
Licence holder
ASIA HEALTHCARE SDN. BHD.
Producer
YANLING NATURAL HYGIENE SDN. BHD.
Published name
PharmaSelect ImmuPro Capsule
Published reference
202207268348T
Registration number
MAL22106071TC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL22106071TC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Astragalus membranaceus
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 May 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line